COMPOSITIONS AND METHODS FOR USE OF ANTIVIRAL DRUGS IN THE TREATMENT OF RETROVIRAL DISEASES RESISTANT TO NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS

The present invention relates to novel compositions comprising an excisioninhibiting bisphosphonate and a nucleoside reverse transcriptase inhibitor. The present invention also relates to methods for preventing or treating retrovirus-related diseases using a composition comprising a bisphosphonate a...

Full description

Saved in:
Bibliographic Details
Main Authors PARNIAK, MICHAEL, OLDFIELD, ERIC, MELLORS, JOHN, W, TOVIAN, ZEV, CHAN, JULIAN, MUN, WENG
Format Patent
LanguageEnglish
French
Published 02.06.2005
Edition7
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to novel compositions comprising an excisioninhibiting bisphosphonate and a nucleoside reverse transcriptase inhibitor. The present invention also relates to methods for preventing or treating retrovirus-related diseases using a composition comprising a bisphosphonate and a nucleoside reverse transcriptase inhibitor. In a specific embodiment, the invention provides methods for preventing or treating AIDS by administering a bisphosphonate-based compound in combination with 3'-azido-3'-deoxythymidine (AZT) to patients infected with AZT­resistant HIV to improve the effectiveness of AZT therapy. L'invention concerne de nouvelles compositions contenant un bisphosphonate inhibant l'excision et un inhibiteur nucléosidique de la transcriptase inverse. L'invention concerne également des méthodes de prévention et de traitement des maladies liées à un rétrovirus, au moyen d'une composition contenant un bisphosphonate et un inhibiteur nucléosidique de la transcriptase inverse. Dans un mode de réalisation, l'invention concerne des méthodes de prévention ou de traitement du SIDA. Ces méthodes consistent à administrer un composé à base de bisphosphonate associé à la 3'-azido-3'-déoxythymidine (AZT) à des patients infectés par un VIH résistant à l'AZT, afin d'améliorer l'efficacité du traitement par AZT.
Bibliography:Application Number: WO2004US29375